ROS1 gene rearrangement and expression of splice isoforms in lung cancer, diagnosed by a novel quantitative RT-PCR assay
Journal Title: Journal of Modern Human Pathology - Year 2016, Vol 1, Issue 3
Abstract
Successful treatment of lung cancer (NSCLC) patients with ROS1 inhibitors depends on the accurate diagnosis of ROS1 gene rearrangements. The approved FISH tests are low-throughput assays difficult to use in daily diagnostic practice. Immunohistochemistry is currently discussed as screening test. We aimed to devise an alternative, sensitive diagnostic test for the rearrangement of ROS1 and to investigate upregulated ROS1 gene expression as potential target in NSCLC. We developed a qRT-PCR assay adapted to RNA isolated from FFPE material and applied it to 695 NSCLC specimens. The reliability to detect ROS1 rearrangements was evidenced by comparison with FISH and immunohistochemistry. qRT-PCR analysis detected unbalanced ROS1 expression indicative of gene rearrangement in 5 (0.7%) and expression of non-rearranged ROS1 transcripts in 65 (9.6%) of 680 interpretable tumors. In comparison with FISH, qRT-PCR accurately typed 99% of 5 rearranged and 121 non-rearranged tumors. Immunohistochemistry detected ROS1 protein expression in 7/8 tumors with gene fusions and 6/35 NSCLC with transcriptional upregulation. To elucidate RNA processing, 12 NSCLC were examined by systematic RT-PCR and sequence analysis. In all 12 NSCLC analyzed, up-regulated gene expression independent of translocation was associated with aberrant expression of fetal transcript isoforms identified here. We conclude that our qRT-PCR assay reliably diagnoses and distinguishes ROS1 rearrangements and expression of non-rearranged transcripts. Immunostaining is a suitable screening tool, but re-examination of ROS1 protein expressing cases by qRT-PCR/FISH is compulsory. The expression of ROS1 splice isoforms – shown here for the first time - may be relevant for ROS1 inhibitor therapy in NSCLC.
Authors and Affiliations
Kalla C, Gruber K, Rosenwald A, Kimmich M, Kohlhäufl M, Friedel G, Ott G
Keywords
Related Articles
- EP ID EP553051
- DOI 10.14312/2397-6845.2016-5
- Views 59
- Downloads 0
Primary osseous amyloidoma - Report of two cases with review of the literature
Amyloidoma, also known as tumoral amyloidosis, is a rare localized subset of amyloidosis without systemic involvement. Amyloid becomes aggregated in the extracellular matrix ofvarious tissues such as the respiratory, uri...
Roles of HMGA proteins in cancer: Expression, pathways, and redundancies
The expression of the High Mobility Group A (HMGA) proteins, their participation in cancer signalling pathways, and their redundant functions have been reviewed in seven types of cancer: breast, colorectal, prostate, lun...
Comparison of the clinicopathologic features of solitary and multifocal papillary thyroid carcinoma and the utility of testing an additional tumor nodule for BRAFV600E in multifocal cases
A retrospective review of the tumor focality and BRAFV600E mutational status of all thyroidectomy cases diagnosed with papillary thyroid carcinoma (PTC) between 1/2010 and 7/2013 was performed. A total of 122 cases were...
Analytic turnaround time study for integrated reporting of pathology results on electronic medical records using the Illuminate system
Timely pathology results are critical for appropriate diagnosis and management of patients. Yet workflows in laboratories remain ad hoc and involve accessing multiple systems with no direct linkage between patient histor...
The changing incidence of gonadal germ cell tumours
Ovarian and testicular germ cell tumour incidence has been studied fairly extensively. An increasing number of male reproductive disorders including an increasing incidence of testicular germ cell tumours have been ident...